Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Virtual Advanced Course on NTRK Gene Fusion: A New Target in Precision Treatment of Cancer 2021

Session 7 - Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations

Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations

Date

07 Dec 2021

Session

Session 7 - Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations

Topics

Targeted Therapy

Tumour Site

Presenters

J-Y. Blay, FR

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.